Macular Hole and Intravitreal Injection of Triamcinolone Acetonide for Macular Edema Due to Central Retinal Vein Occlusion

Abstract

Purpose.

To report a case of macular hole progression after intravitreal injection of triamcinolone acetonide (IVTA) for chronic macular edema secondary to nonischemic central retinal vein occlusion (CRVO).

Methods.

A 33-year-old woman with massive macular edema after CRVO underwent IVTA. Optical coherence tomography (OCT) and fluorescein angiography were performed before and after the procedure.

Results.

At the 1-week IVTA injection control, the patient's best-corrected visual acuity improved from 20/400 to 20/200 and OCT detected a progression of macular hole stage.

Conclusions.

IVTA steroid injection may provide a significant improvement in macular edema, but injection-related complications may occur such as this uncommon macular reaction resulting in permanent visual loss.

Keywords

Central retinal vein occlusion Macular edema Macular hole Triamcinolone acetonide

Get full access to this article

View all access options for this article.

References

Jonas

J.B.

, Kreissig

, Degenring

R.F.

Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002; 240: 782–3.

Park

C.H.

, Jaffe

G.J.

, Fekrat

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 136: 419–25.

Bashshur

Z.F.

, Ma'luf

R.N.

, Allam

, Jurdi

F.A.

, Haddad

R.S.

, Noureddin

B.N.

Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 2004; 122: 1137–40.

M.S.

, Gottlieb

J.L.

, Kahana

Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004; 122: 1131–6.

Soto-Pedre

, Hernaez-Ortega

M.C.

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2004; 137: 596.

Cekic

, Chang

, Tseng

J.J.

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Retina 2005; 25: 846–50.

Williamson

T.H.

, O'Donnell

Intravitreal triamcinolone acetonide for cystoid macular edema in non ischemic central retinal vein occlusion. Am J Ophthalmol 2005; 139: 860–6.

Jager

R.D.

, Aiello

L.P.

, Patel

S.C.

, Cunningham

E.T.

Jr. Risks of intravitreous injection: a comprehensive review. Retina 2004; 24: 676–98.

Gass

J.D.

Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 1988; 106: 629–39.

10.

Azzolini

, Patelli

, Brancato

Correlation between optical coherence tomography data and biomicroscopic interpretation of idiopathic macular hole. Am J Ophthalmol 2001; 132: 348–55.

11.

Aiello

L.P.

, Brucker

A.J.

, Chang

Evolving guidelines for intravitreous injections. Retina 2004; 24: S3–19.

12.

The Central Vein Occlusion Study Group M Report. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 1995; 102: 1425–33.